Saving two birds with one stone…

Chemicals used to protect crops require rigorous safety testing, usually in animals, to ensure that they are not harmful to humans or the environment. A recently published study has called into question some aspects of the approach to safety testing required in certain countries and regions suggesting an effective way to evaluate plant protection products whilst using fewer animals. Lead author, Sam Maynard, from Syngenta, tells the NC3Rs more about the findings.

Northern Bobwhite Quail

Northern Bobwhite Quail – most frequently used test species for avian acute toxicity testing (Image taken from Wikimedia Commons)

Plant protection products (PPPs) are vital to the production of a safe, affordable and abundant supply of food worldwide. Safety testing of PPPs currently requires the use of in vivo animal experiments to provide the highest quality information on the hazard of a substance to humans and environmental non-target species.

The NC3Rs leads an expert group investigating how the 3Rs can be applied to ecotoxicology (environmental toxicology) testing. At one of the group’s meetings, the necessity of some of the regional requirements for avian acute toxicity studies on PPPs was discussed. These avian acute toxicity studies involve the administration of the test substance to birds in the laboratory to assess lethal effects. A project was initiated with the aim of investigating how available data could be utilised more effectively to reduce the number of such studies, and the number of animals, used when these studies are performed.

When registering a PPP globally there are often differing regulatory requirements that must be met in each country. The specifics of which tests are required in different countries or regions are not fully harmonized.

Plant protection products (PPPs) consist of two types of constituents: the active substance (chemical which is biologically active against the pest), and the co-formulants (e.g. solvents and dispersants) which facilitate the delivery of the active chemical to the target pest or weed. In general testing is always required on the active substance, as this is generally the biologically active component of the PPP and is therefore usually the component which will drive any potential toxicity. However, in order to ensure that formulation (mixing with co-formulants) does not increase toxicity, some countries require additional testing of the PPP (active substance + all co-formulants). Experience has shown that this is rarely the case, and the work described in this paper aims to demonstrate this for avian toxicity.

An extensive database of high quality avian acute toxicity studies from five plant protection companies was collated. The database contained 383 regulatory studies on PPPs and their respective active substances. This significant data set was utilized to demonstrate that:

  • Active substances with low toxicity rarely produce a toxic PPP when formulated.
  • When active substances do show measurable toxicity, this toxicity can be accurately used to predict the toxicity of the PPP without requiring further testing.
  • When conducting acute avian toxicity tests using the latest testing guideline, which employs a sequential testing procedure (where fewer birds are dosed in stages), can reduce bird usage by over 60% over those guidelines which do not incorporate animals reduction methods.

These analyses provide strong evidence that data obtained from avian acute toxicity studies on PPPs provide little additional valuable information on toxicity over and above that obtained for the active substances (studies which are always required). We hope that the analyses presented can provide confidence in predictive approaches to PPP assessment as used in Europe such that regulation in other regions can be harmonized to reduce testing.

The work has resulted in a peer reviewed publication, which has been made open access (courtesy of NC3Rs and Syngenta) to inform and encourage uptake of the recommendations across the global agrochemical community.

Maynard SK, Edwards P, Wheeler JR (2014). Saving two birds with one stone – using active substance avian acute toxicity data to predict formulated plant protection product toxicity. Environ. Toxicol. Chem. DOI: 10.1002/etc.2590

Embedding the 3Rs in charity-funded research

How can charities go further to ensure that they are only using animals in research where absolutely necessary, and that the welfare of those animals and effective design of those studies is always of paramount importance? Dr Martin Turner, Senior Policy Advisor at the Association of Medical Research Charities (AMRC), explains how the AMRC are working together with the NC3Rs to make the 3Rs a priority in charity-funded research.


Continue reading

Hosting an institutional workshop on the 3Rs

The University of Aberdeen recently organised and hosted a large workshop to promote the 3Rs, which included a flagship presentation by the NC3Rs. The workshop included speakers and attendees from Aberdeen and from across the bioscience sector. It was well attended and ultimately successful as an informative workshop that engaged delegates and met its overarching objective of widespread promotion of the 3Rs to academics and support staff alike. Iain Grant, Policy Adviser at the university, who was involved in bringing the event together, tells the NC3Rs about his experience of organising the day.

Dr CallumDr MacCallum presenting on the day

Defining the Objectives

Continue reading

Working together to CRACK dementia

The UnTangle Challenge from CRACK IT brings together great minds from the charity sector, industry and academia to help unravel the mysteries surrounding how the tau protein is linked with the progression of Alzheimer’s disease. Dr Eric Karran, Director of Research at Alzheimer’s Research UK, tells the NC3Rs why the charity is excited to be involved with the Challenge.

Tau protein

Tau protein via Wikimedia Commons

Continue reading

NC3Rs-funded research findings now available for all

Amidst the ever-changing landscape of scholarly communication, open access publishing has emerged as an attractive option for disseminating research findings further. In May 2014, the NC3Rs joined the Europe PubMed Central research funder’s consortium, meaning that NC3Rs-funded research papers will now be openly and easily available to all. Laura McGuinness, Communications Officer at the NC3Rs, takes a look at some of the many benefits of making 3Rs research free to access. 

pile of papers large

Continue reading